Is this you? Create Your Porfile
Avatar

Ruf Sven

Aventis Pharma

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Ruf Sven is active.

Explore More

Publication

Featured researches published by Ruf Sven.

Archive | 2014

Naphthyl sulfonamide derivatives as KEAP-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders

Szillat Hauke; Ruf Sven; Glombik Heiner; Kallus Christopher; Engel Karl-Christian; Guossregen Stefan; Schmol Dieter; Kannt Aimo; Dudda Dr Angela; Monecke Peter; Elshorst Dr Bettina

Archive | 2003

Cyclische N-substituierte alpha-Iminocarbonsäuren zur selektiven Inhibierung von Kollagenase

Stahl Petra; Kirsch Reinhard; Ruf Sven; Wehner Volkmar; Weithmann Klaus-Ulrich

Archive | 2018

ΥΠΟΚΑΤΕΣΤΗΜΕΝΑ ΠΑΡΑΓΩΓΑ 3-ΕΤΕΡΟΑΡΟΫΛΑΜΙΝΟ-ΠΡΟΠΙΟΝΙΚΟΥ ΟΞΕΟΣ ΚΑΙ ΧΡΗΣΗ ΤΟΥΣ ΩΣ ΦΑΡΜΑΚΕΥΤΙΚΑ

Ruf Sven; Sadowski Thorsten; Wirth Klaus; Schreuder Herman; Buning Christian

Archive | 2017

ΠΑΡΑΓΩΓΑ 3-ΕΤΕΡΟΑΡΟΥΛΑΜΙΝΟ-ΠΡΟΠΙΟΝΙΚΟΥ ΟΞΕΟΣ ΚΑΙ ΧΡΗΣΗ ΤΟΥΣ ΩΣ ΦΑΡΜΑΚΕΥΤΙΚΑ

Ruf Sven; Pernerstorfer Josef; Sadowski Thorsten; Horstick Georg; Schreuder Herman; Buning Christian; Wirth Klaus

Archive | 2017

ΠΑΡΑΓΩΓΑ ΟΞΥΓΟΝΟ- ΥΠΟΚΑΤΕΣΤΗΜΕΝΟΥ 3-ΕΤΕΡΟΑΡΟΫΛΑΜΙΝΟ- ΠΡΟΠΙΟΝΙΚΟΥ ΟΞΕΟΣ ΚΑΙ Η ΧΡΗΣΗ ΤΟΥΣ ΩΣ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΟΥΣΙΕΣ

Ruf Sven; Pernerstorfer Josef; Sadowski Thorsten; Horstick Georg; Schreuder Herman; Buning Christian; Olpp Thomas; Scheiper Bodo; Wirth Klaus

Archive | 2016

derivados de ácido 3-heteroaroilamino-propiônico substituídos e seu uso como farmacêuticos

Buning Christian; Schreuder Herman; Wirth Klaus; Ruf Sven; Sadowski Thorsten

Archive | 2016

3-HETEROAROYLAMINOPROPIONSYREDERIVATER OG DERES ANVENDELSE SOM FARMACEUTIKA

Ruf Sven; Pernerstorfer Josef; Sadowski Thorsten; Schreuder Herman; Buning Christian; Wirth Klaus; Horstick Georg

Archive | 2016

3-HETEROAROYLAMINO-PROPIONIC ACID DERIVATIVES AND THEIR USE AS MEDICINE

Ruf Sven; Pernerstorfer Josef; Sadowski Thorsten; Horstick Georg; Schreuder Herman; Buning Christian; Wirth Klaus

Archive | 2016

Aryl substituted naphthyl sulfonamide derivatives as keap-1 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders

Szillat Hauke; Ruf Sven; Glombik Heiner; Kallus Christopher; Engel Dr Karl-Christian; Guessregen Stefan; Schmoll Dieter; Kannt Aimo; Dudda Dr Angela; Monecke Peter; Elshorst Dr Bettina

Archive | 2015

OXYGENSUBSTITUEREDE 3-HETEROAROYLAMINOPROPIONSYRE-DERIVATER OG DERES ANVENDELSE SOM FARMACEUTIKA

Ruf Sven; Pernerstorfer Josef; Sadowski Thorsten; Horstick Georg; Schreuder Herman; Buning Christian; Olpp Thomas; Scheiper Bodo; Wirth Klaus

Explore More

Collaboration

Dive into the Ruf Sven's collaboration.

Top Co-Authors
Avatar

Ritter Kurt

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Strobel Hartmut

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

El-Ahmad Youssef

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Lesuisse Dominique

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Nemecek Conception

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Kadereit Dieter

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Malleron Jean-Luc

Rhône-Poulenc

View shared research outputs
Top Co-Authors
Avatar

Bouchard Herve

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Hittinger Augustin

Aventis Pharma

View shared research outputs
Top Co-Authors
Avatar

Benard Didier

Aventis Pharma

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge